Cardiac involvement in patients with myeloproliferative disorders.
暂无分享,去创建一个
[1] W. Markiewicz,et al. Cardiac involvement in patients with primary antiphospholipid syndrome. , 1991, Journal of the American College of Cardiology.
[2] M. Nicholls,et al. Cardiac involvement in systemic lupus erythematosus detected by echocardiography. , 1990, The American journal of cardiology.
[3] T. Barbui,et al. Hemostatic complications in young patients with essential thrombocythemia. , 1990, The American journal of medicine.
[4] B. Brenner,et al. Abnormalities of fibrinolytic parameters in patients with myeloproliferative diseases , 1990 .
[5] M. Lockshin,et al. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. , 1989, The American journal of medicine.
[6] A. Wehmeier,et al. Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease. , 1989, Haemostasis.
[7] A. Nagler,et al. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases. , 1988, Archives of internal medicine.
[8] G. Maurer,et al. Echocardiographic findings in systemic lupus erythematosus. , 1988, The American journal of cardiology.
[9] W. Lubbe,et al. Cerebral and valve lesions in SLE: association with antiphospholipid antibodies. , 1988, The Journal of rheumatology.
[10] I. Palacios,et al. Mitral regurgitation after percutaneous balloon mitral valvuloplasty in adults: evaluation by pulsed Doppler echocardiography. , 1988, Journal of the American College of Cardiology.
[11] P. Mugnier,et al. Polycythaemia vera in young people: an analysis of 58 cases diagnosed before 40 years , 1987, British journal of haematology.
[12] B. Brenner,et al. Influence of splenectomy on hemostasis in agnogenic myeloid metaplasia. , 1987, Haemostasis.
[13] R. Berger,et al. Essential thrombocythemias. Clinical evolutionary and biological data , 1986, Cancer.
[14] J. Goldberg,et al. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. , 1986, Seminars in hematology.
[15] D. Valla,et al. Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. , 1985, Annals of internal medicine.
[16] R. Davis,et al. Acute thrombotic complications of myeloproliferative disorders in young adults. , 1985, American journal of clinical pathology.
[17] A. Van Tosh,et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.
[18] B. Amor,et al. Libman-Sacks endocarditis: the diagnostic importance of two-dimensional echocardiography. , 1985, British journal of rheumatology.
[19] J. Steketee,et al. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. , 1985, Annals of internal medicine.
[20] A. Dawson,et al. Measurement of platelet life‐span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets , 1984, British journal of haematology.
[21] Z. Ruggeri,et al. Acquired von Willebrand's disease in the myeloproliferative syndrome. , 1984, Blood.
[22] A. Schafer. Bleeding and thrombosis in the myeloproliferative disorders. , 1984, Blood.
[23] E. Massey,et al. Neurologic manifestations of essential thrombocythemia. , 1983, Annals of internal medicine.
[24] E. Ladusans,et al. Lacunar infarcts in polycythaemia with raised packed cell volumes. , 1983, British medical journal.
[25] A S Abbasi,et al. Pulsed Doppler echocardiography in the diagnosis and estimation of severity of aortic insufficiency. , 1982, The American journal of cardiology.
[26] B. Sandok,et al. Two-dimensional echocardiography in patients with focal cerebral ischemia. , 1981, Annals of internal medicine.
[27] D. Decristofaro,et al. Detection and Estimation of the Degree of Mitral Regurgitation by Range‐gated Pulsed Doppler Echocardiography , 1980, Circulation.
[28] R. Virmani,et al. Thrombocytosis, coronary thrombosis and acute myocardial infarction. , 1979, The American journal of medicine.
[29] R. Purcell,et al. The chronic sequelae of non-A, non-B hepatitis. , 1979, Annals of internal medicine.
[30] T. Pearson,et al. VASCULAR OCCLUSIVE EPISODES AND VENOUS HÆMATOCRIT IN PRIMARY PROLIFERATIVE POLYCYTHÆMLX , 1978, The Lancet.
[31] S Simonsen,et al. Determination of Pressure Gradient in Mitral Stenosis with a Non‐invasive Ultrasound Doppler Technique , 2009 .
[32] A. Theologides,et al. ACETYLSPERMIDINES IN HUMAN URINE , 1975, The Lancet.
[33] B. Bulkley,et al. Mitral valve disease of systemic lupus erythematosus. A cause of severe congestive heart failure reversed by valve replacement. , 1975, The American journal of medicine.
[34] W. Roberts,et al. Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease. , 1975, The American journal of cardiology.
[35] L. Wasserman,et al. Abnormalities of platelet function in patients with polycythemia vera. , 1973, Cancer research.
[36] A. Dawson,et al. The influence of the platelet count on the incidence of thrombotic and haemorrhagic complications in polycythaemia vera , 1970, Postgraduate medical journal.
[37] J. Fairbairn,et al. Erythermalgia: Review of 51 Cases , 1964, Circulation.
[38] T. Thiede,et al. Complications and causes of death in polycythaemia vera. , 2009, Acta medica Scandinavica.
[39] E. Libman,et al. A HITHERTO UNDESCRIBED FORM OF VALVULAR AND MURAL ENDOCARDITIS , 1924 .